Medical School News and Research

RSS

Study may help overcome some obstacles to the development of nanoparticle-based drugs

Using nanoparticles to deliver cancer drugs offers a way to hit tumors with large doses of drugs while avoiding the harmful side effects that often come with chemotherapy.

21 Jul 2022

Alzheimer's disease and anti-amyloid therapeutic approaches

An estimated 50 million people around the world have Alzheimer's disease (AD), and perhaps twice that number are unknowingly "incubating" the disease during its long presymptomatic period.

21 Jul 2022

Supplementing diet with amino acid taurine could be a viable nutritional strategy to combat aging

When our cells process the oxygen we breathe and the food we eat every day in order to survive, they generate potentially toxic by-products popularly known as "free radicals".

20 Jul 2022

Nanotherapeutic compound may help treat inflammation, brain injury in patients with severe COVID-19

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chances of death, according to a new study from UTHealth Houston and other institutions.

20 Jul 2022

Modifying lifestyle risk factors can offset a genetic risk of stroke, study shows

People who are genetically at higher risk for stroke can lower that risk by as much as 43% by adopting a healthy cardiovascular lifestyle, according to new research led by UTHealth Houston, which was published today in the Journal of the American Heart Association.

20 Jul 2022

New way to test vaccines may be as rigorous and stringent as exposure to field strains of malaria

Malaria is the deadliest mosquito-borne parasitic infection of humans. In 2021, after a century of research, the World Health Organization (WHO) approved the world's first malaria vaccine.

20 Jul 2022

New vaccine shows promise to fight Lassa virus

Researchers at the University of Texas Medical Branch have achieved success with a new vaccine developed to fight Lassa Virus, a pathogen that causes Lassa fever.

19 Jul 2022

Study finds decline in cardiovascular mortality rates over the last 20 years, but racial disparities remain

While it's well-established that Black adults experience a disproportionately high burden of cardiovascular risk factors and disease in comparison to white adults in the United States, few gender-based analyses of recent national trends exist.

19 Jul 2022

Tissue nanotransfection technology can serve as a non-viral, topical, gene-editing delivery device, research shows

The Indiana Center for Regenerative Medicine and Engineering (ICRME) at Indiana University School of Medicine is home to tissue nanotransfection (TNT) regenerative medicine technology that achieves functional tissue reprogramming in the live body.

19 Jul 2022

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

A new study involving hospitalized women in six African countries from the University of Maryland School of Medicine's (UMSOM) Institute of Human Virology (IHV) showed that pregnant women with SARS-CoV-2, the virus that causes COVID-19, had double the risk of being admitted to the intensive care unit (ICU) and four-times the risk of dying in-hospital than pregnant women who did not have COVID-19.

19 Jul 2022

Cardiovascular mortality has declined over the past two decades, but disparities persist

Research supported by the National Institutes of Health shows that cardiovascular-related deaths have declined over the past two decades, but disparities remain.

19 Jul 2022

Research describes one of the ways the SARS-CoV-2 virus recruits cells to replicate

An article published in the journal Frontiers in Cellular and Infection Microbiology reports a study by researchers at the State University of Campinas (UNICAMP) and the University of São Paulo (USP) in Brazil showing how a human protein interacts with a SARS-CoV-2 protein, and describing one of the ways the virus that causes COVID-19 recruits cells to replicate.

18 Jul 2022

Cytokine-based cancer immunotherapy: current progress and future prospects

In this interview, News-Medical talks to Dr. Shuang Zhou about cytokine-base cancer immunotherapy, the current state of the field, and future prospects.

From Sino Biological Inc. 18 Jul 2022

Best available chemotherapy for HIV-related Kaposi sarcoma would save lives and be cost-effective in Africa

Although antiretroviral therapy has markedly improved survival in people with AIDS-associated Kaposi sarcoma (a type of cancer caused by a virus), the condition is still a life-threatening problem in low- and middle-income countries.

15 Jul 2022

New disease-modifying therapy for Alzheimer's disease may involve whole blood exchange

A novel, disease-modifying therapy for Alzheimer's disease may involve the whole exchange of blood, which effectively decreased the formation of amyloid plaque in the brains of mice, according to a new study from UTHealth Houston.

15 Jul 2022

Study: Prescribing rate of non-opioid pain medications increased after 2016 CDC guideline

After the Centers for Disease Control and Prevention released a guideline for prescribing opioids to patients experiencing chronic pain in 2016, the prescribing rate of non-opioid pain medication increased each year above and beyond what would be expected based on the preexisting trends, a new study finds.

15 Jul 2022

New tool uses existing EHR data to identify avoidable hospital transfers of nursing home residents

The Avoidable Transfer Scale, an innovative tool that uses data commonly included in a nursing home resident's electronic health record to identify and characterize potentially avoidable hospitalizations, highlights issues that can be handled in the nursing home itself.

15 Jul 2022

The Mark Foundation for Cancer Research announces latest ASPIRE awards for eight outstanding projects

The Mark Foundation for Cancer Research announced eight outstanding research projects to receive its latest class of ASPIRE awards.

14 Jul 2022

Phase I clinical trial of new blocking antibody therapy shows promising results for the treatment of advanced medulloblastoma

Effective and safe treatments are needed for medulloblastoma - the most common type of cancerous brain tumor in children - especially for patients whose cancer has spread to the spinal cord.

14 Jul 2022

A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision does not improve sufficiently, gives results similar to starting off with the higher-priced drug.

14 Jul 2022

Medical School News and Research

Study may help overcome some obstacles to the development of nanoparticle-based drugs

Alzheimer's disease and anti-amyloid therapeutic approaches

Supplementing diet with amino acid taurine could be a viable nutritional strategy to combat aging

Nanotherapeutic compound may help treat inflammation, brain injury in patients with severe COVID-19

Modifying lifestyle risk factors can offset a genetic risk of stroke, study shows

New way to test vaccines may be as rigorous and stringent as exposure to field strains of malaria

New vaccine shows promise to fight Lassa virus

Study finds decline in cardiovascular mortality rates over the last 20 years, but racial disparities remain

Tissue nanotransfection technology can serve as a non-viral, topical, gene-editing delivery device, research shows

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

Cardiovascular mortality has declined over the past two decades, but disparities persist

Research describes one of the ways the SARS-CoV-2 virus recruits cells to replicate

Cytokine-based cancer immunotherapy: current progress and future prospects

Best available chemotherapy for HIV-related Kaposi sarcoma would save lives and be cost-effective in Africa

New disease-modifying therapy for Alzheimer's disease may involve whole blood exchange

Study: Prescribing rate of non-opioid pain medications increased after 2016 CDC guideline

New tool uses existing EHR data to identify avoidable hospital transfers of nursing home residents

The Mark Foundation for Cancer Research announces latest ASPIRE awards for eight outstanding projects

Phase I clinical trial of new blocking antibody therapy shows promising results for the treatment of advanced medulloblastoma

A stepped regimen of anti-VEFG drugs leads to good vision outcomes in diabetic macular edema

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News